CA2277377C - Controlled release composition - Google Patents

Controlled release composition Download PDF

Info

Publication number
CA2277377C
CA2277377C CA002277377A CA2277377A CA2277377C CA 2277377 C CA2277377 C CA 2277377C CA 002277377 A CA002277377 A CA 002277377A CA 2277377 A CA2277377 A CA 2277377A CA 2277377 C CA2277377 C CA 2277377C
Authority
CA
Canada
Prior art keywords
composition according
diglycerol
composition
active material
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002277377A
Other languages
English (en)
French (fr)
Other versions
CA2277377A1 (en
Inventor
Kare Larsson
Helena Ljusberg-Wahren
Niels Krog
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandberg Development AB
Original Assignee
GS Development AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GS Development AB filed Critical GS Development AB
Publication of CA2277377A1 publication Critical patent/CA2277377A1/en
Application granted granted Critical
Publication of CA2277377C publication Critical patent/CA2277377C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002277377A 1997-01-13 1998-01-08 Controlled release composition Expired - Fee Related CA2277377C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9700061-6 1997-01-13
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
PCT/SE1998/000009 WO1998030206A1 (en) 1997-01-13 1998-01-08 Controlled release composition

Publications (2)

Publication Number Publication Date
CA2277377A1 CA2277377A1 (en) 1998-07-16
CA2277377C true CA2277377C (en) 2007-12-18

Family

ID=20405393

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002277377A Expired - Fee Related CA2277377C (en) 1997-01-13 1998-01-08 Controlled release composition

Country Status (9)

Country Link
US (1) US6660278B1 (enExample)
EP (1) EP0954287B1 (enExample)
JP (1) JP2001508773A (enExample)
AT (1) ATE243024T1 (enExample)
AU (1) AU5583298A (enExample)
CA (1) CA2277377C (enExample)
DE (1) DE69815659T2 (enExample)
SE (1) SE511313C2 (enExample)
WO (1) WO1998030206A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
US6887487B2 (en) * 2001-10-19 2005-05-03 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
US20050049210A1 (en) * 2003-08-27 2005-03-03 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
SG173326A1 (en) * 2004-06-04 2011-08-29 Camurus Ab Liquid depot formulations
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036983A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Pre-dried drug delivery coating for use with a stent
US8124127B2 (en) 2005-10-15 2012-02-28 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
WO2006036964A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Barrier layer
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US8288348B2 (en) * 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US8574627B2 (en) 2006-11-06 2013-11-05 Atrium Medical Corporation Coated surgical mesh
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
EP2393472B1 (en) 2008-12-05 2019-06-05 NanoMed Holdings Pty Ltd Amphiphile prodrugs
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2011050388A1 (en) * 2009-10-30 2011-05-05 Monash University Liquid crystal composition and method of use
KR101663551B1 (ko) * 2010-05-18 2016-10-07 후지필름 가부시키가이샤 카로티노이드 함유 조성물 및 그 제조 방법
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
LT2877155T (lt) 2012-07-26 2021-02-25 Camurus Ab Opioidų vaisto formos
PL2877155T3 (pl) 2012-07-26 2021-05-17 Camurus Ab Formulacje opioidowe
MX391097B (es) 2017-11-27 2025-03-21 Umecrine Cognition Ab FORMULACIÓN FARMACÉUTICA DE 3A-ETINIL-3ß-HIDROXIANDROSTAN-17-ONA OXIMA.
CN113166189A (zh) 2018-04-26 2021-07-23 纳米医学控股有限公司 吉西他滨两亲性前体药物
SG11202107877WA (en) 2018-06-21 2021-08-30 NanoMed Holdings Pty Ltd Platinum-based amphiphile prodrugs
US20240083107A1 (en) * 2021-01-29 2024-03-14 Ioi Oleo Gmbh Polyglycerol fatty acid ester-containing composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5321393B2 (enExample) * 1974-10-19 1978-07-03
US5264460A (en) * 1988-05-30 1993-11-23 Deutsche Solvay-Werke Gmbh Process for preparing nonionic surfactants
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
IE65045B1 (en) * 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
DE69229779T2 (de) 1991-04-19 1999-12-23 Lds Technologies, Inc. Konvertierbare mikroemulsionsverbindungen
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US6013269A (en) * 1994-10-12 2000-01-11 The Procter & Gamble Company Cosmetic make-up compositions
SE504582C2 (sv) 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky

Also Published As

Publication number Publication date
AU5583298A (en) 1998-08-03
CA2277377A1 (en) 1998-07-16
ATE243024T1 (de) 2003-07-15
EP0954287B1 (en) 2003-06-18
US6660278B1 (en) 2003-12-09
EP0954287A1 (en) 1999-11-10
SE9700061L (sv) 1998-07-14
DE69815659T2 (de) 2004-04-29
DE69815659D1 (de) 2003-07-24
SE9700061D0 (sv) 1997-01-13
SE511313C2 (sv) 1999-09-06
JP2001508773A (ja) 2001-07-03
WO1998030206A1 (en) 1998-07-16

Similar Documents

Publication Publication Date Title
CA2277377C (en) Controlled release composition
Constantinides Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects
CA2182576C (en) Bilayer preparations
AU691250B2 (en) Lipophilic carrier preparations
US4379755A (en) Gelatinizing agent composition, and gel and aqueous emulsion prepared therefrom
US5589455A (en) Cyclosporin-containing soft capsule compositions
US9522377B2 (en) Method for improving the properties of amphiphile particles
US5603951A (en) Cyclosporin-containing soft capsule compositions
MXPA01009817A (es) Composiciones farmaceuticas orales las cuales contienen trigliceridos de cadena larga y tensioactivos lipofilicos.
ZA200209520B (en) Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds.
NO844144L (no) Legemiddeltilberedning
WO1988000059A1 (en) A controlled-release composition for a biologically active material dissolved or dispersed in an l2-phase
JPH11508592A (ja) シクロスポリンからなる生物活性組成物
KR100258674B1 (ko) 안정성이 개선된 레티노이드를 함유하는 친수형 화장료의 제조방법
WO2000074653A1 (en) Oil-core compositions for the sustained release of hydrophobic drugs
JP6148416B2 (ja) コアシェル構造体及び外用剤
JPS58121209A (ja) 乳化型外用組成物
PL201177B1 (pl) Jadalna mikroemulsja woda w oleju, sposób jej wytwarzania oraz jej zastosowanie
US6235312B1 (en) Liquid crystalline phase drug delivery vehicle
EP1670436B1 (en) Composition comprising ether lipid
JP2016117681A (ja) コアシェル構造体を含有する製剤
JPH10330250A (ja) メナテトレノン油性製剤
JPS60192546A (ja) 可食性液状配合油
CA1247881A (en) Method of preparing controlled-release preparations for biologically active materials and resulting compositions
BRPI0720489A2 (pt) Cápsulas de gelatina compreendendo um ácido

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130108